IP Library Granted Patent US 10,603,333
Granted Patent B2
US 10,603,333 · App. 15/837,273 · Granted Mar 31, 2020

Process for producing a particulate composition comprising an hydrous crystalline 2-o-alpha-d-glucosyl-ascorbic acid

Inventors: Takashi Shibuya (Okayama, JP); Seisuke Izawa (Okayama, JP); Tomoyuki Nishimoto (Okayama, JP); Shigeharu Fukuda (Okayama, JP); Toshio Miyake (Okayama, JP)
Assignee: HAYASHIBARA CO., LTD.
A61K31/7048A61K9/16C07H17/04C12P19/18C12P19/60C12Y204/01019
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,603,333
App. No.
15/837,273
Granted
Mar 31, 2020
Kind
B2
Abstract

The invention provides a process for enabling the production of a particulate composition containing anhydrous crystalline ascorbic acid 2-glucoside that does not significantly cake even when the production yield of ascorbic acid 2-glucoside does not reach 35% by weight. The process for producing a particulate composition containing anhydrous crystalline ascorbic acid 2-glucoside, which comprises allowing a CGTase to act on a solution containing either liquefied starch or dextrin and L-ascorbic acid and then allowing a glucoamylase to act on the resulting solution to obtain a solution with an ascorbic acid 2-glucoside production yield of at least 27%, purifying the obtained solution to increase the ascorbic acid 2-glucoside content to a level of over 86% by weight, precipitating anhydrous crystalline ascorbic acid 2-glucoside by a controlled cooling method or pseudo-controlled cooling method, collecting the precipitated anhydrous crystalline ascorbic acid 2-glucoside, and ageing and drying the collected anhydrous crystalline ascorbic acid 2-glucoside.

Claims (4)

1. A particulate composition comprising anhydrous crystalline 2-O-α-D-glucosyl-L-ascorbic acid,

which comprises 2-O-α-D-glucosyl-L-ascorbic acid in an amount of over 98.0% by weight but 99.8% by weight or lower, on a dry solid basis;

which has a degree of crystallinity of 90% or higher but 98% or lower for anhydrous crystalline 2-O-α-D-glucosyl-L-ascorbic acid, when calculated based on a profile of powder X-ray diffraction analysis of said composition;

and which has a reducing power of the whole particulate composition being less than one percent by weight.

Assignments (2)
CHANGE OF NAME Recorded Mar 18, 2025
From: HAYASHIBARA CO., LTD.
To: NAGASE VIITA CO., LTD.
Reel/Frame 070538/0828 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 11, 2017
From: SHIBUYA, TAKASHI; IZAWA, SEISUKE; NISHIMOTO, TOMOYUKI; FUKUDA, SHIGEHARU; MIYAKE, TOSHIO
To: HAYASHIBARA CO., LTD.
Reel/Frame 044353/0552 →
Priority Claims (6)
JP 2009-204142 · Sep 3, 2009 · national
JP 2009-298857 · Dec 28, 2009 · national
JP 2010-117835 · May 21, 2010 · national
JP 2010-190139 · Aug 26, 2010 · national
JP 2011-049571 · Mar 7, 2011 · national
JP 2011-050807 · Mar 8, 2011 · national
Continuity (5)
Continuation 14879280 · Oct 9, 2015
Continuation 14295546 · Jun 4, 2014
Division 13980223
Continuation In Part 12875786 · Sep 3, 2010
Related Publication 20180092936A1 · Apr 5, 2018